NOS2 and melanoma: Our data suggest that iNOS regulates mPGES1 activity through a posttranslational NT modification, which ultimately enhances PGE2 production; that iNOS activates the mPGES1/PGE2 pathway; and that the cross talk between iNOS and mPGES1 promotes inflammation, which favors melanoma progression (24).